Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

38.44
-0.2250-0.58%
Volume:851.93K
Turnover:32.75M
Market Cap:4.27B
PE:-26.86
High:39.38
Open:38.64
Low:37.45
Close:38.66
52wk High:41.14
52wk Low:8.47
Shares:111.19M
Float Shares:82.57M
Volume Ratio:0.26
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:17.87
PE(LYR):-25.11

Loading ...

Amylyx reports Q4 EPS (30c), consensus (34c)

TIPRANKS
·
Mar 03

Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q4 Net Loss $0.30 a Share, vs. FactSet Est of $0.29 Loss

MT Newswires Live
·
Mar 03

Amylyx Pharmaceuticals Q4 net loss beats estimates

Reuters
·
Mar 03

Amylyx posts FY 2025 net loss of USD 144.7 million, down 52.0%

Reuters
·
Mar 03

Amylyx Pharma Q4 EPS $(0.30) Beats $(0.36) Estimate

Benzinga Earnings
·
Mar 03

Amylyx Pharmaceuticals Inc - Cash Runway Expected to Fund Operations Through Potential Avexitide Commercialization and Into 2028

THOMSON REUTERS
·
Mar 03

Amylyx Pharmaceuticals Q4 Operating Income USD -36.605 Million VS. Ibes Estimate USD -40.4 Million

THOMSON REUTERS
·
Mar 03

Amylyx Pharmaceuticals Q4 Operating Expenses USD 36.605 Million

THOMSON REUTERS
·
Mar 03

Amylyx Pharmaceuticals Inc - Phase 3 Lucidity Trial Topline Data Anticipated in Q3 2026 & Commercial Launch in 2027

THOMSON REUTERS
·
Mar 03

Press Release: Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Mar 03

This Amylyx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

Benzinga_recent_news
·
Mar 03

Amylyx Pharmaceuticals Inc : Stifel Initiates Coverage With Buy Rating; Target Price $21

THOMSON REUTERS
·
Mar 03

Amylyx initiated with a Buy at Stifel

TIPRANKS
·
Mar 03

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 02

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 27

Amylyx Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference and Leerink Global Healthcare Conference

Reuters
·
Feb 26